125 related articles for article (PubMed ID: 35400719)
41. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
42. Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.
Iwahashi M; Nakamori M; Nakamura M; Noguchi K; Ueda K; Nakatani Y; Ojima T; Ishida K; Naka T; Yamaue H
Anticancer Res; 2005; 25(5):3453-9. PubMed ID: 16101163
[TBL] [Abstract][Full Text] [Related]
43. A preliminary study of preoperative chemotherapy combining irinotecan and cisplatin in patients with gastric cancer with unresectable para-aortic lymph node metastases.
Yamao T; Ohta K; Ohyama S; Ishihara S; Chin K; Maruyama M; Takahashi T; Nakajima T
Jpn J Clin Oncol; 2004 May; 34(5):255-61. PubMed ID: 15231860
[TBL] [Abstract][Full Text] [Related]
44. Collagen gel droplet culture method to examine in vitro chemosensitivity.
Kobayashi H
Methods Mol Med; 2005; 110():59-67. PubMed ID: 15901927
[TBL] [Abstract][Full Text] [Related]
45. [A case of S-1/CDDP-resistant recurrent gastric cancer responsive to capecitabine/CDDP].
Sunami T; Tauchi J; Sakashita K; Yukimoto K; Sawada R; Sakamoto K
Gan To Kagaku Ryoho; 2014 May; 41(5):649-51. PubMed ID: 24917015
[TBL] [Abstract][Full Text] [Related]
46. Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701.
Kawase T; Imamura H; Goto M; Kimura Y; Ueda S; Matsuyama J; Nishikawa K; Sugimoto N; Fujita J; Tamura T; Fukushima N; Kawakami H; Sakai D; Kurokawa Y; Shimokawa T; Satoh T
Int J Clin Oncol; 2021 Oct; 26(10):1871-1880. PubMed ID: 34453640
[TBL] [Abstract][Full Text] [Related]
47. Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test.
Ochiai T; Nishimura K; Watanabe T; Kitajima M; Nakatani A; Nagayasu K; Naito S; Sato T; Kishine K; Abe Y; Hara C; Yamada S; Mashiko S; Nagaoka I
Oncol Lett; 2017 Nov; 14(5):6045-6052. PubMed ID: 29113244
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of ramucirumab plus paclitaxel therapy for advanced gastric cancer patients treated previously with docetaxel-containing chemotherapy.
Kakuta T; Yabusaki H; Bamba T; Aizawa M; Nogami H; Nomura T; Matsuki A; Maruyama S; Takii Y; Nakagawa S
Int J Clin Oncol; 2021 Apr; 26(4):684-693. PubMed ID: 33389346
[TBL] [Abstract][Full Text] [Related]
49. [A case of gastric cancer with peritoneal dissemination who achieved long survival by successive treatments with S-1 in combination with CDDP, paclitaxel and irinotecan].
Seshimo K; Kanagawa T; Yamashita Y; Oishi M; Kodera M; Yamamura M; Katoh H; Ikeda H; Yokomichi N; Kobayashi K; Takita K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1741-4. PubMed ID: 19838039
[TBL] [Abstract][Full Text] [Related]
50. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
51. [Intra-peritoneal chemotherapy for scirrhous gastric cancer].
Ikeguchi M; Kuroda H; Matsunaga T; Fukuda K; Saito H; Tatebe S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2058-60. PubMed ID: 20037322
[TBL] [Abstract][Full Text] [Related]
52. [Irinotecan+cisplatin and irradiation are effective for brain metastases of gastric cancer--two case reports].
Rino Y; Sekino Y; Yamada T; Nakayama T; Arai H; Kanari M; Saeki H; Yukawa N; Wada N; Masuda M; Higashida T; Imada T
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1095-8. PubMed ID: 17637547
[TBL] [Abstract][Full Text] [Related]
53. [Combination Chemotherapy Including Intraperitoneal(IP)Administration of Paclitaxel(PTX)followed by PTX, CDDP and S-1Triplet Chemotherapy for CY1P0 Gastric Cancer].
Shinkai M; Imano M; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Kimura Y; Imamoto H; Furukawa H; Yasuda T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1355-1357. PubMed ID: 29394632
[TBL] [Abstract][Full Text] [Related]
54. Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
Yamagami W; Banno K; Kawaguchi M; Yanokura M; Kuwabara Y; Hirao N; Susumu N; Tsukazaki K; Aoki D
Chemotherapy; 2007; 53(2):137-41. PubMed ID: 17308380
[TBL] [Abstract][Full Text] [Related]
55. [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Mihara K; Yamashiro N; Nishiya S; Kemmochi T; Ito Y; Egawa T; Nagashima A
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2358-60. PubMed ID: 25731522
[TBL] [Abstract][Full Text] [Related]
56. Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism.
Maeda S; Sugiura T; Saikawa Y; Kubota T; Otani Y; Kumai K; Kitajima M
Cancer Sci; 2004 Aug; 95(8):679-84. PubMed ID: 15298732
[TBL] [Abstract][Full Text] [Related]
57. 5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.
Murata S; Yamamoto H; Shimizu T; Naitoh H; Yamaguchi T; Kaida S; Takebayashi K; Miyake T; Tani T; Tani M
J Surg Oncol; 2018 Mar; 117(4):671-677. PubMed ID: 29266509
[TBL] [Abstract][Full Text] [Related]
58. [A case of synchronous hepatocellular carcinoma successfully treated by S-1 and cisplatin (CDDP) as neoadjuvant chemotherapy for gastric cancer].
Oka T; Onoda Y; Ohashi R; Izumi S; Suzuka I; Shiota K
Gan To Kagaku Ryoho; 2009 May; 36(5):863-6. PubMed ID: 19461196
[TBL] [Abstract][Full Text] [Related]
59. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106).
Kurimoto K; Ishigure K; Mochizuki Y; Ishiyama A; Matsui T; Ito S; Nakayama H; Tanaka N; Kobayashi D; Sakamoto J; Nakao A; Kodera Y
Gastric Cancer; 2015 Apr; 18(2):354-9. PubMed ID: 24838732
[TBL] [Abstract][Full Text] [Related]
60. Predicting the chemosensitivity of ovarian and uterine cancers with the collagen gel droplet culture drug-sensitivity test.
Nagai N; Minamikawa K; Mukai K; Hirata E; Komatsu M; Kobayashi H
Anticancer Drugs; 2005 Jun; 16(5):525-31. PubMed ID: 15846118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
